Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As CMS Chief, Brooks-LaSure Could Turn Quickly To Medicare Drug Spending Reforms

Feb 19 2021

• By Cathy Kelly

shutterstock/Manatt, Phelps & Phillips, LLP — President Biden Appears To Have Settled On CHIQUITA BROOKS-LASURE For CMS Administrator

Related Content

Medicaid Rebate Reform: A Sign Of Minimal Drug Pricing Threats Or A Warning Of More To Come?

Feb 11 2021

CMS Administrator Search: 3 Obama-Era Officials Being Considered To Lead Biden’s Medicare Agency

Jan 27 2021

Additional Topics

United States Policy Pricing Strategies Medicaid Reimbursement BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.